AGREEMENTSchedule 13d Agreement • February 5th, 2015 • Children's Hospital of Philadelphia Foundation • Biological products, (no disgnostic substances)
Pursuant to Rule 13d-l(k)(l) under the Securities Exchange Act of 1934, the undersigned hereby agree that only one statement containing the information required by Schedule 13D need be filed with respect to the ownership by each of the undersigned of shares of Common Stock of Spark Therapeutics, Inc.
